AQR Capital Management LLC Grows Stock Position in Humana Inc. $HUM

Key Points

• AQR Capital Management LLC significantly increased its stake in Humana Inc. by 3,257.5%, acquiring an additional 1,127,973 shares, bringing its total ownership to 1,162,600 shares worth approximately $307.6 million.
• Several institutional investors, including Vanguard Group and GAMMA Investing LLC, have also increased their positions in Humana, indicating strong institutional interest in the company.
• Humana reported earnings of $6.27 per share in its latest quarter, falling short of estimates, yet the company’s revenue was up by 9.6% year-over-year, totaling $32.39 billion.

AQR Capital Management LLC lifted its stake in Humana Inc. (NYSE:HUM - Free Report) by 3,257.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,162,600 shares of the insurance provider's stock after acquiring an additional 1,127,973 shares during the period. AQR Capital Management LLC owned 0.96% of Humana worth $307,624,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the stock. Federation des caisses Desjardins du Quebec increased its position in Humana by 21.7% during the 1st quarter. Federation des caisses Desjardins du Quebec now owns 4,176 shares of the insurance provider's stock valued at $1,105,000 after buying an additional 746 shares in the last quarter. Chiron Capital Management LLC increased its position in Humana by 99.9% during the 1st quarter. Chiron Capital Management LLC now owns 6,003 shares of the insurance provider's stock valued at $1,588,000 after buying an additional 3,000 shares in the last quarter. PDT Partners LLC increased its position in Humana by 229.9% during the 1st quarter. PDT Partners LLC now owns 29,301 shares of the insurance provider's stock valued at $7,753,000 after buying an additional 20,420 shares in the last quarter. Focus Partners Advisor Solutions LLC increased its position in Humana by 226.9% during the 1st quarter. Focus Partners Advisor Solutions LLC now owns 4,978 shares of the insurance provider's stock valued at $1,317,000 after buying an additional 3,455 shares in the last quarter. Finally, Graham Capital Management L.P. acquired a new position in Humana during the 1st quarter valued at about $995,000. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

HUM has been the topic of several recent analyst reports. Robert W. Baird reduced their target price on Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Bank of America increased their price objective on Humana from $285.00 to $312.00 and gave the company a "neutral" rating in a report on Tuesday. Piper Sandler cut their price objective on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Sanford C. Bernstein increased their price objective on Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a report on Friday. Finally, Royal Bank Of Canada increased their price objective on Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a report on Thursday, August 21st. Seven analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. Based on data from MarketBeat, Humana currently has an average rating of "Hold" and an average target price of $289.24.

Humana Stock Performance

Shares of HUM traded down $4.07 during mid-day trading on Friday, reaching $307.94. The company had a trading volume of 1,504,536 shares, compared to its average volume of 1,364,503. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $369.17. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $37.04 billion, a P/E ratio of 23.63, a PEG ratio of 1.83 and a beta of 0.44. The stock has a 50 day moving average of $261.46 and a two-hundred day moving average of $256.47.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. On average, analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.1%. Humana's dividend payout ratio is currently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.